Zee Ent, Ultratech, Mazagon Dock, ICICI Bank, DLF, Inox, and Other Stocks to Monitor

Stocks to Monitor on January 21: Dalal Street was expected to have a poor start on Thursday, as indicated by the GIFT Nifty on the NSE IX trading 75.5 points, or 0.36 percent, down at 21,141.50. These are a number of equities that will be watched closely today for different reasons.

Inox India: Today marks the company’s bourses debut. The cost of issuance is Rs 660.

Zee Entertainment: Sony Pictures Networks has consented to hold talks with the organization in order to potentially extend the deadline for concluding the merger agreement.

Allcargo Logistics: Compared to the previous year, the LCL volume for November decreased by a little 0.35 percent. According to the report, demand is as muted as expected, which is consistent with a challenging macroeconomic climate for international commerce. It also said that shipping lines are anticipated to steer clear of the Red Sea due to Yemen’s ongoing strikes, which might result in lengthier voyages, messed up sailing plans, higher transit expenses, and short-term changes in freight rates. Additionally, it has set January 2, 2024, as the record date for its 3:1 bonus share offering.

Ultratech Cement: The business has reached a deal to buy a 26% share in Clean Max Terra.

Mazagon Dock Shipbuilders: The defense ministry has awarded the business an order valued at Rs 1615 crore for the provision of six boats to the Indian Coast Guards (ICG).

Cochin Shipyard: It has also agreed to a contract of Rs 488.25 crore with the Ministry of Defence.

ICICI Bank: Sandeep Batra has been reappointed as Executive Director, effective December 23, with approval from the RBI.

Tips Industries: The founders of music record labels, Kumar and Ramesh Taurani, have sold a 6.07 percent share in the business.

DLF: In the midst of a robust real estate market, the business has sold standalone floors and commercial plots for almost Rs 1,400 crore in Gurugram and Panchkula, Haryana.

Flair Writing: The company’s Q2 sales increased by 4.2% on a quarter-over-quarter basis to Rs 257 crore, while its profit increased by 3% to Rs 33 crore.

AstraZeneca Pharma: Enhertu will be introduced in India in January 2024. Treatment for adult patients with metastatic or incurable HER2-positive breast cancer with trastuzumab deruxtecan (Enhertu) is recommended.

Praveg: The government has given it a work order to construct and oversee the upkeep of at least fifty tents at Agatti Island, UT, Lakshwadeep. On December 26, the board will also convene to discuss moneyraising.

Jyoti Structure: A Rs 175 crore rights issuance has been authorized by the board.

Macro International: Through a preferential offer, it obtained Rs 15 crore at a price of Rs 30 per share.